Evaluation of the efficacy of totally implantable venous access port in breast cancer patients undergoing chemotherapy.

ABSTRACT:

Objective

The use of Totally Implantable Venous Access Port (TIVAP) has gained importance in chemotherapy for cancer patients due to its ability to reduce complications compared to conventional central venous catheters. Chemotherapy for breast cancer often requires long-term venous access, and the choice of device can impact both treatment efficacy and patient quality of life. This study randomly divided 355 breast cancer chemotherapy patients, who were treated from January 2022 to January 2023, into the TIVAP group (n = 177) and the control group (n = 178) to evaluate the application effect of TIVAP.

Methods

The patients in the TIVAP group used totally implantable venous access ports, while those in the control group used central venous catheters. We compared the clinical e

SUBMITTER: Guo Y 

PROVIDER: S-EPMC11933549 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature